Barclays analyst Andrew Mok raised the firm’s price target on UnitedHealth (UNH) to $386 from $352 and keeps an Overweight rating on the shares as part of a Q3 earnings preview for the health care facilities and managed care group. The firm continues to think Medicare is the most stable, Medicaid the most uncertain, and the Affordable Care Act exchanges are inflecting positively from both a fundamental and policy perspective.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- ‘Keep Buying,’ Affirm Several Analysts about UnitedHealth Group (UNH) Ahead of Q3
- Why UnitedHealth Group Stock (UNH) Gets a Price Target Boost from Wells Fargo
- Mixed options sentiment in UnitedHealth with shares up 1.82%
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts?